Newcastle disease virus therapy of human tumor xenografts: Antitumor effects of local or systemic administration

Cancer Letters

Volumn 172, Issue 1, 2001, Pages 27-36

  Phuangsab, Anan ^a   Lorence, Robert M ^b   Reichard, Kirk W ^a,c   Peeples, Mark E ^b   Walter, Robert J ^a,b  

^a Jr Hospital of Cook County   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Newcastle disease virus; Oncolytic virus; Tumor xenografts

Indexed keywords

ANTINEOPLASTIC AGENT; BUFFER; PHOSPHATE; SODIUM CHLORIDE;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER RECURRENCE; CANCER REGRESSION; CANCER THERAPY; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBROSARCOMA; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; MOUSE; NEUROBLASTOMA; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR REGRESSION; TUMOR XENOGRAFT; ULTRAVIOLET RADIATION; VIRUS REPLICATION;

AVES; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE;

EID: 0035935255     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00617-6     Document Type: Article

References (29)

1. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
2. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
3. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
4. Reovirus therapy of tumors with activated Ras pathway
5. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial
6. The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts
7. Viruses as oncolytic agents: A new age for 'therapeutic' viruses?
8. Scientific interest in Newcastle disease virus is reviving
9. Newcastle disease virus: Virus particle and RNA synthesis in different host cells and at different temperatures
10. Newcastle disease virus selectively kills human tumor cells
11. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy
12. Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy
13. Strain variation and nuclear association of Newcastle disease virus matrix protein
14. Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines
15. Brain tumor research in nude mice
16. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts
17. Effects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude mice
18. Newcastle disease virus as an antineoplastic agent
19. A ten yearfollow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate
20. Viral oncolysate in the management of malignant melanoma. II. Clinical studies
21. A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate
22. Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virus
23. Successful application of nononcogenic virus for antimetastatic cancer immunotherapy
24. Newcastle disease virus as an antineoplastic agent: Induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity
25. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: Effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis
26. Interferon production by inactivated Newcastle disease virus in cell cultures and in mice
27. Karyotype alterations in human ovarian carcinoma cells during long-term cultivation and nude mouse passage
28. Regression of human tumor xenografts following intravenous treatment using PV701, a naturally attenuated oncolytic strain of Newcastle disease virus